Trial ID or NCT#

NCT03179800

Status

recruiting iconRECRUITING

Purpose

The objective of this study is to evaluate the safety and effectiveness of the MobiusHD System in a prospective, randomized, double-blind, sham-controlled multi-center pivotal study.

Official Title

CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™

Eligibility Criteria

Ages Eligible for Study: 18 Years to 80 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Tara I. Chang
Tara I. Chang
Nephrologist - Kidney specialist, Refractory hypertension specialist, Heart and kidney disease specialist, Nephrologist
Associate Professor of Medicine (Nephrology) at the Stanford University Medical Center
Vivek Bhalla, MD
Vivek Bhalla, MD
Nephrologist
Associate Professor of Medicine (Nephrology) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

SPECTRUM